The latest developments from suppliers of ingredients, development and manufacturing services, and related technologies for pharmaceutical and biopharmaceutical development and production.
Sterling Pharma Solutions, a Dudley, UK-headquartered contract development and manufacturing organization, is investing £6 million ($8 million) to expand its pilot plant at its UK site to increase capacity by 33% and enhance the site’s production...
Lonza is investing in mid-scale mammalian cell biomanufacturing capacity and new cell-therapy suites at its site in Portsmouth, New Hampshire.
Lonza plans to install multiple 6,000-liter bioreactors at the site with building expected to...
Almac Group, a Craigavon, UK-based contract development and manufacturing organization (CDMO) of active pharmaceutical ingredients (APIs) and drug products, has appointed David Taylor as Head of Manufacturing Operations. Taylor joined the Almac...
CordenPharma, a contract development and manufacturing organization of active pharmaceutical ingredients (APIs) and drug products, has expanded its commercial oligonucleotide API manufacturing at its CordenPharma Colorado site in Boulder,...
Catalent Pharma Solutions has made leadership changes within its biologics business. The changes follows its $950-million acquisition in 2017 of Cook Pharmica, a Bloomington, Indiana contract development and manufacturing organization of biologic...
Camargo Pharmaceutical Services, a Cincinnati, Ohio-based provider of drug-development services, including 505(b)(2) drug development and global equivalents, has appointed Daniel S. Duffy as the firm’s new Chief Executive Officer. Kenneth V....
WuXi Biologics, part of WuXi AppTec, a contract service provider, plans to invest EUR 325 million ($392 million) in a new biologics drug-substance manufacturing facility in Mullagharlin, Dundalk, County Louth, Ireland.
The company says the...
Avid Bioservices, a Tustin, California-based contract development and manufacturing organization (CDMO) of biopharmaceutical products derived from mammalian cell culture and a wholly owned subsidiary of Peregrine Pharmaceuticals, has provided an...
STA Pharmaceutical, a subsidiary of WuXi AppTec, has signed an investment agreement with the government of Shanghai, Jinshan District, China to build a new research & development (R&D) center.
The new facility will support WuXi STA’s...
Cell and Gene Therapy Catapult (CGT Catapult), a center of excellence funded by Innovate UK, the UK government’s innovation agency, to support cell-therapy organizations, has opened a cell- and gene- therapy manufacturing center in Stevenage,...
Grand River Aseptic Manufacturing (GRAM), a Grand Rapids, Michigan-based provider of sterile-manufacturing services, has purchased a Bausch+Ströbel fully integrated high-speed filling line with a SKAN isolator.
The Bausch+Ströbel filler can fill...
Dipharma, a Baranzate, Italy-headquartered active pharmaceutical ingredients manufacturer, has agreed to acquire Kalexsyn, a Kalamazoo, Michigan-headquartered contract research organization (CRO) providing chemistry services to the biotechnology...
Catalent Pharma Solutions plans to invest $5 million in the creation of a new drug development center of excellence (CoE) at its Somerset, New Jersey facility and headquarters.
The investment will see the site focus on preclinical to clinical...
AMRI, a contract research, development, and manufacturing organization, has renewed a 10-year contract worth up to $39.5 million with the National Institutes of Health (NIH) Blueprint Neurotherapeutics Network (BPN). The renewal means AMRI will...
Sharp Packaging Services, a part of UDG Healthcare and a company in contract packaging and clinical supply services, has invested $11 million to increase its global cold-storage and syringe assembly capacity.
The additional investment in Groninger...
